profit from every $100 of sales.
$0$100
Accendra Health
$0.15-4.28% today
-89.8% in 1 year
1-year low $0.151-year high $1.95
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Accendra Health sold, what it kept, and what it did with the cash.
Sales went from $9.96 billion in 2022 to $2.76 billion in 2025, with -$1.10 billion of profit last year.
SalesProfit
Accendra Health vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Accendra Health | No profit yet | ||
 Guardian Pharmacy Services | 64.3× · Very expensive | ||
 Prestige Consumer Healthcare | 11.0× · Cheap | ||
 Great Elm Group | 5.1× · Cheap | ||
 Wellgistics Health | No profit yet |
AI analysis
An AI analyst reads Accendra Health's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 9,955 | 2,553 | 2,680 | 2,762 | |
| 1,826 | 1,217 | 1,280 | 1,289 | |
| 277 | 215 | 198 | 222 | |
| 368 | 342 | -41 | 220 | |
| 22 | -41 | -363 | -1,101 | |
| 0.29 | -0.54 | -4.73 | -14.31 | |
| 18.3% | 47.7% | 47.8% | 46.7% | |
| 2.8% | 8.4% | 7.4% | 8.0% | |
| 0.2% | -1.6% | -13.5% | -39.8% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 5,386 | 5,093 | 4,656 | 2,452 |
| Cash | 69 | 243 | 28 | 282 |
| Total debt | 2,716 | 2,320 | 1,931 | 2,120 |
| Total liabilities | 4,441 | 4,169 | 4,070 | 2,913 |
| 946 | 924 | 586 | -461 | |
| 76 | 76 | 77 | 77 | |
| 3.0% | 3.2% | -7.0% | 0.2% | |
| 2.4% | -4.5% | -61.9% | 238.8% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 325 | 741 | 161 | -102 | |
| 167 | 179 | 183 | 201 | |
| 158 | 562 | -21 | -303 | |
| Dividends paid | 0 | 0 | – | – |
| – | 0 | 0 | 10 | |
| 21 | 14 | 17 | 13 |
Valuation
- –
- 0.2×
- –
- -0.5×
- 0.0×
- –
- 8.4×
- -2,714.5%
- -9,856.6%
- 0.0%
Profitability
- 46.7%
- 8.0%
- -39.8%
- 7.1%
- 1.4%
- -13.1%
- 268.7%
- -45.5%
- 2.1%
- –
Growth
- −34.8%
- –
- −339.1%
- −61.2%
- +1.4%
Financial health
- 1.6×
- -1.40
- 26.9%
- 0.2×
- 0.49
- 0.43
- 1.12
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 37%of 958
Bottom 45%of 888
Bottom 3%of 889
What analysts expect
- Average price target
- $4.00
- Range
- $3.00 – $5.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 11, 2026 | -0.04 | -0.06 | +33.3% |
| Feb 19, 2026 | 0.21 | 0.22 | −4.5% |
| Oct 30, 2025 | 0.25 | 0.23 | +8.7% |
| Aug 11, 2025 | 0.26 | 0.27 | −3.7% |
| May 8, 2025 | 0.23 | 0.20 | +15.0% |
| Feb 28, 2025 | 0.55 | 0.53 | +3.8% |
| Nov 4, 2024 | 0.42 | 0.40 | +5.0% |
| Aug 2, 2024 | 0.36 | 0.33 | +9.1% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
28No pass
Benjamin Graham
0No pass
Philip Fisher
34No pass
Peter Lynch
0No pass
Joel Greenblatt
0No pass
Charlie Munger
27No pass
Terry Smith
21No pass
Questions about Accendra Health
Is Accendra Health a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Accendra Health AI analysis
What does Accendra Health do?
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. It is in Medical - Distribution.
Does Accendra Health pay a dividend?
No. Accendra Health does not pay a dividend at the moment; in 2025 it returned $10.2 million to shareholders by buying back its own shares.
Is Accendra Health stock halal?
No. Accendra Health does not pass our halal screen: its debt is 18,987% of its market value, at or above the 33% limit. How we check
How has Accendra Health stock done over the past year?
Down 89.8% over the past twelve months, to $0.15. It traded between $0.15 and $1.95 and is 92.5% below its high.
Who are Accendra Health's competitors?
The largest listed companies in the same industry are Guardian Pharmacy Services, Prestige Consumer Healthcare, Great Elm Group and Wellgistics Health. The peers table on this page compares their profit, growth and price with Accendra Health's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.